Us Bancorp \De\ Xeris Biopharma Holdings, Inc. Put Options Transaction History
Us Bancorp \De\
- $74.1 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding XERS
# of Institutions
203Shares Held
84.7MCall Options Held
132KPut Options Held
69.4K-
Black Rock Inc. New York, NY10.3MShares$50.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.11MShares$39.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.29MShares$20.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.41MShares$16.6 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$16.2 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $663M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...